Latest Safety News

Life360, Inc. reported a return to profitability in Q2 2025, driven by strong subscription growth and strategic partnerships, while also announcing a leadership transition and issuing $320 million in convertible notes.

LGI Limited reported a robust FY25 with 14% EBITDA growth driven by expanded renewable energy capacity and carbon credit sales, while setting ambitious FY26 guidance of 25-30% EBITDA growth.

LGI Limited reported a robust FY25 with a 13.6% increase in underlying EBITDA to $17.4 million, expanded renewable capacity by 44%, and declared a fully franked dividend. The company’s strategic investments in battery storage and biogas infrastructure position it well in Australia’s energy transition.

Coronado Global Resources reported breakeven EBITDA in Q2 2025 despite a 24% drop in coal prices, driven by significant cost reductions and ramping up of expansion projects. The company forecasts stronger profitability and cash flow in the second half, supported by improved production and liquidity.

Southern Cross Electrical Engineering has announced over $110 million in new and renewed contracts, reinforcing its position in Australia’s infrastructure services and manufacturing sectors.

SGH Ltd reported solid FY25 results with 8% EBIT growth, margin expansion, and a 17% dividend increase, setting a confident tone for FY26. The diversified industrial services group demonstrated robust cash flow and reduced leverage despite mixed divisional performances.

Etherstack’s US subsidiary has locked in a significant seven-year Master Supply Agreement with AT&T, promising steady revenue and validating its mission-critical telecom technology.

Island Pharmaceuticals has raised $350,000 through an options exercise by substantial shareholder MWP Partners, reinforcing confidence in its antiviral drug development pipeline.

Syntara Limited has received FDA guidance recommending a Phase 2 controlled trial for its lead drug amsulostat in myelofibrosis, setting the stage for a pivotal Phase 3 study. The company is poised to refine its clinical strategy while advancing a diverse pipeline with key data milestones ahead.

DroneShield launches SentryCiv, a subscription-based AI-powered counter-drone solution designed to protect civilian critical infrastructure from emerging aerial threats.

JB Hi-Fi Limited reported a robust FY2025 with revenue up 10% to $10.55 billion and net profit after tax rising 5.4% to $462.4 million. The company declared a fully franked final dividend and a special dividend, while announcing a CEO succession plan.

Noxopharm Limited has successfully completed the second dose cohort in its HERACLES Phase 1 trial for SOF-SKN™, confirming safety and tolerability and moving forward to a higher dose. This progress marks a key step in developing a novel autoimmune disease treatment.